David Berk

Vice President, Clinical Development at Arcutis Biotherapeutics

Dr. Berk is a board-certified Pediatric Dermatologist. Prior to joining Arcutis in 2019, he was Section Head for Medical Dermatology at Allergan, Inc.. Previously, he was in academic practice as an Assistant Professor at Washington University in St. Louis, and has authored more than one hundred publications. He completed his Dermatology residency at Washington University in St. Louis and his fellowship training in Pediatric Dermatology at Stanford University, received his M.D. from Stanford University, and received his A.B. (summa cum laude) in Molecular Biology from Princeton University.


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Arcutis Biotherapeutics

3 followers

Arcutis (Nasdaq: ARQT) was founded in 2016 to address significant unmet needs in medical dermatology. The company is a clinical-stage biopharmaceutical company focused on developing and commercializing best-in-class products.


Industries

Employees

51-200

Links